Literature DB >> 12202652

Imatinib GIST keeps finding new indications: successful treatment of dermatofibrosarcoma protuberans by targeted inhibition of the platelet-derived growth factor receptor.

Charles L Sawyers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12202652     DOI： 10.1200/JCO.2002.20.17.3568

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  7 in total

1.  Anlotinib inhibits synovial sarcoma by targeting GINS1: a novel downstream target oncogene in progression of synovial sarcoma.

Authors:  L Tang; W Yu; Y Wang; H Li; Z Shen
Journal:  Clin Transl Oncol       Date:  2019-04-08       Impact factor: 3.405

2.  Genetic predictors of MEK dependence in non-small cell lung cancer.

Authors:  Christine A Pratilas; Aphrothiti J Hanrahan; Ensar Halilovic; Yogindra Persaud; Junichi Soh; Dhananjay Chitale; Hisayuki Shigematsu; Hiromasa Yamamoto; Ayana Sawai; Manickam Janakiraman; Barry S Taylor; William Pao; Shinichi Toyooka; Marc Ladanyi; Adi Gazdar; Neal Rosen; David B Solit
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

3.  Pitfalls in immunohistochemical assessment of EGFR expression in soft tissue sarcomas.

Authors:  C Kersting; J Packeisen; B Leidinger; B Brandt; R von Wasielewski; W Winkelmann; P J van Diest; G Gosheger; H Buerger
Journal:  J Clin Pathol       Date:  2006-02-03       Impact factor: 3.411

4.  Chemical genetics screen for enhancers of rapamycin identifies a specific inhibitor of an SCF family E3 ubiquitin ligase.

Authors:  Mariam Aghajan; Nao Jonai; Karin Flick; Fei Fu; Manlin Luo; Xiaolu Cai; Ikram Ouni; Nathan Pierce; Xiaobo Tang; Brett Lomenick; Robert Damoiseaux; Rui Hao; Pierre M Del Moral; Rati Verma; Ying Li; Cheng Li; Kendall N Houk; Michael E Jung; Ning Zheng; Lan Huang; Raymond J Deshaies; Peter Kaiser; Jing Huang
Journal:  Nat Biotechnol       Date:  2010-06-27       Impact factor: 54.908

5.  Personalization of targeted therapy in advanced thyroid cancer.

Authors:  Poupak Fallahi; Silvia Martina Ferrari; Valeria Mazzi; Roberto Vita; Salvatore Benvenga; Alessandro Antonelli
Journal:  Curr Genomics       Date:  2014-06       Impact factor: 2.236

6.  Emerging role of multikinase inhibitors for refractory thyroid cancer.

Authors:  Cesar A Perez; Belisario A Arango; Michel Velez; Luis E Raez; Edgardo S Santos
Journal:  Biologics       Date:  2012-08-08

Review 7.  Potential Therapeutic Targets in Uterine Sarcomas.

Authors:  Tine Cuppens; Sandra Tuyaerts; Frédéric Amant
Journal:  Sarcoma       Date:  2015-10-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.